The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    The status of marijuana in multiple sclerosis

    Researchers from the University of Patras Medical School in Greece have reviewed the data.

    • There’s no significant decline in cognition (reasoning) after relatively short-term administration of cannabis-based medicinal extracts.
    • However, there are also no large long-term systematic clinical studies of cannabis-based medicinal extracts in patients with multiple sclerosis (MS).

    The bottom line?
    The authors conclude, there are many unresolved issues, including the possible side effects of cannabis-based medicinal extracts on cognition.

    Actually, that data do exist.

    Researchers at the University of Toronto in Canada recently reported the downside of street cannabis in patients with MS. Marijuana smokers perform 50% slower on tests of information processing speed compared to non-smoking MS patients. And, marijuana smokers are more likely to be depressed and anxious.

    7/7/08 10:43 JR

    Leave a Comment

    You must be logged in to post a comment.